USA Financial Formulas Has $85,000 Stock Holdings in Globe Life Inc. $GL

USA Financial Formulas reduced its position in shares of Globe Life Inc. (NYSE:GL) by 89.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 606 shares of the company’s stock after selling 5,237 shares during the period. USA Financial Formulas’ holdings in Globe Life were worth $85,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. CX Institutional raised its holdings in Globe Life by 5.6% in the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after buying an additional 96 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC grew its holdings in Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock worth $646,000 after acquiring an additional 99 shares during the last quarter. KLP Kapitalforvaltning AS grew its holdings in Globe Life by 0.5% during the 3rd quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company’s stock worth $3,145,000 after acquiring an additional 100 shares during the last quarter. Clearstead Advisors LLC increased its position in Globe Life by 1.9% in the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after acquiring an additional 100 shares during the period. Finally, Journey Strategic Wealth LLC increased its position in Globe Life by 5.0% in the 3rd quarter. Journey Strategic Wealth LLC now owns 2,103 shares of the company’s stock valued at $301,000 after acquiring an additional 101 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analyst Weigh In

GL has been the topic of a number of recent research reports. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Evercore set a $157.00 target price on Globe Life in a research report on Wednesday, February 18th. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a report on Thursday. Finally, TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus target price of $172.00.

Insider Activity

In other news, EVP Robert Edward Hensley sold 712 shares of Globe Life stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total value of $101,524.08. Following the completion of the transaction, the executive vice president directly owned 8,580 shares of the company’s stock, valued at approximately $1,223,422.20. This trade represents a 7.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 82,807 shares of company stock worth $12,041,286. 2.11% of the stock is owned by insiders.

Globe Life Stock Up 0.1%

Shares of NYSE GL opened at $135.26 on Monday. The company has a market capitalization of $10.61 billion, a P/E ratio of 9.61 and a beta of 0.46. Globe Life Inc. has a 52-week low of $109.38 and a 52-week high of $152.71. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The company’s 50 day moving average price is $141.45 and its 200-day moving average price is $138.84.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the company earned $3.14 earnings per share. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.0%. This is an increase from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life’s payout ratio is currently 7.67%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.